T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.09.28.20202929
Publication URI: http://dx.doi.org/10.1101/2020.09.28.20202929
Type: Preprint